Search Login Register

infliximab (Remicade) Summary

Description: a chimeric monoclonal antibody to TNFalpha for the treatment of Crohn's disease & rheumatoid arthritis

Also Known As: Remicade; Centocor brand of infliximab; Essex brand of infliximab; MAb cA2; Schering brand of infliximab Show All >>

Networked: 5733 relevant articles (1132 outcomes, 959 trials/studies) for this Drug

Key Diseases for which infliximab is Relevant

  1. Crohn Disease (Crohn's Disease) : 363 outcomes 218 studies in 1562 results
  2. Ulcerative Colitis : 128 outcomes 103 studies in 574 results
  3. Rheumatoid Arthritis : 125 outcomes 195 studies in 1033 results
  4. Psoriasis (Pustulosis Palmaris et Plantaris) : 114 outcomes 93 studies in 568 results
  5. Necrosis : 75 outcomes 47 studies in 465 results
Show All >>

Drugs Related to infliximab

  1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  2. adalimumab (Humira)
  3. TNFR-Fc fusion protein (etanercept)
  4. Methotrexate (Mexate)
  5. infliximab (Remicade)
  6. Azathioprine (Imuran)
  7. Phenobarbital (Luminal)
  8. Adrenal Cortex Hormones (Corticosteroids)
  9. CDP870
  10. Antibodies
Show All >>

Therapies Related to infliximab

  1. Biological Therapy
  2. Colectomy
  3. Retreatment
  4. Remission Induction
  5. Aftercare (After-Treatment)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.